Emerging evidence-based physical rehabilitation for Multiple Sclerosis - Towards an inventory of current content across Europe

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Rasova, Kamila ^a   Feys, Peter ^b   Henze, Thomas ^c   van Tongeren, Hans ^d   Cattaneo, Davide ^e   Jonsdottir, Johanna ^e   Herbenova, Alena ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PHL University College   (Belgium)

^c Reha Zentrum Nittenau   (Germany)

^d Sclerosecenter in Haslev ^*  (Denmark)

^e IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EUROPE; EVIDENCE BASED MEDICINE; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NEUROPSYCHOLOGICAL TEST; NOTE; PHYSIOTHERAPY; REHABILITATION; ARTICLE; HISTORY; HUMAN; METHODOLOGY;

EUROPE; EVIDENCE-BASED MEDICINE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MULTIPLE SCLEROSIS; PHYSICAL THERAPY MODALITIES; REHABILITATION;

EID: 77955497456     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-76     Document Type: Note

References (51)

1. Thompson AJ. Symptomatic management and rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2001, 71(Suppl 2):22-27.
2. Henze T, Rieckmann P, Toyka KV. Symptomatic treatment of Multiple Sclerosis. Eur Neurol 2006, 56:78-105. 10.1159/000095699, 16966832.
3. Khan F, Turner-Stokes L, Ng L, Kilpatrick T. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev 2007, (2):CD006036.
4. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et al. AFFIRM Investigators. A randomised, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006, 354(9):899-910. 10.1056/NEJMoa044397, 16510744.
5. Kozak T, Havrdova E, Pitha J, et al. High dose immunosupressive therapy with PBCP support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 2000, 25(5):525-531. 10.1038/sj.bmt.1702180, 10713630.
6. Goodkin DE, Rudick RA, et al. Low dose (7,5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol 1995, 37:30-40. 10.1002/ana.410370108, 7818255.
7. Barkhof F, Hommes OR, Scheltens P, Valk J. Quantitative MRI changes in gadolinium-DPTA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology 1991, 41:1219-1222.
8. Wade D. Rehabilitation research-time for a change of focus. The Lancet Neurology 2002, 1(4):209..
9. Richardson D. Physical therapy in spasticity. Eur J Neurol 2002, 9(Suppl 1):17-22. 10.1046/j.1468-1331.2002.0090s1017.x, 11918645.
10. Nadeau SE. A paradigm shift in neurorehabilitation. Lancet Neurol 2002, 1(2):126-130. 10.1016/S1474-4422(02)00044-3, 12849517.
11. Pelletier J, Audoin B, Reuter F, Ranjeva JP. Plasticity in MS: from functional imaging to rehabilitation. Int MS J 2009, 16:26-31.
12. Khan F, Pallant JF, Brand C, Kilpatrick TJ. Effectiveness of Rehabilitation Intervention in persons with Multiple sclerosis: A Randomized Controlled Trial. J Neurol Neurosurg Psychiatry 2008, 79(11):1230-1235. 10.1136/jnnp.2007.133777, 18535027.
13. Freeman JA, Langgdon DW, Hobart JC. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 1997, 2:236-244.
14. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?. Neurology 1999, 52(1):50-56.
15. Kidd D, Thompson AJ. Prospective study of neurorehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997, 62(4):423-424. 10.1136/jnnp.62.4.423, 1074115, 9120472.
16. Dalgas U, Stenager E, Ingemann-Hansen T. Multiple sclerosis and physical exercise: recommendations for the application of resistance, endurance and combined training. Mult Scler 2008, 14:35-53. 10.1177/1352458507079445, 17881393.
17. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev 2005, (1):CD003980.
18. Romberg A, Virtanen A, Ruutiainen J. Long-term exercise improves functional impairment but not quality of life in multiple sclerosis. J Neurol 2005, 252(7):839-845. 10.1007/s00415-005-0759-2, 15765197.
19. Romberg A, Virtanen A, Ruutiainen J, Aunola S, Karppi SL, Vaara M, et al. Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study. Neurology 2004, 63(11):2034-2038.
20. Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 2002, 8:161-168. 10.1191/1352458502ms779oa, 11990874.
21. World Health Organization International Classification of Functioning, Disability and Health (ICF). Pocket-sized Book 2001, ISBN-13 9789241545440, World Health Organization.
22. Kesselring J, Coenen M, Cieza A, Thompson A, Kostanjsek N, Stucki G. Developing the ICF Core Sets for multiple sclerosis to specify functioning. Mult Scler 2008, 14(2):252-254. 10.1177/1352458507082615, 17986511.
23. Khan F, Pallant JF. Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis. Disabil Rehabil 2007, 29(3):205-213. 10.1080/09638280600756141, 17364771.
24. Motl RW, McAuley E. Pathways between physical activity and quality of life in adults with multiple sclerosis. Health Psychol 2009, 28(6):682-689. 10.1037/a0015985, 19916636.
25. Petajan JH, Gappmaier E, White AT. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurology 1996, 39:432-441.
26. EMSP Code of Good Practice in MS, May 2007 - revised in March 2008. EMSP.
27. Haigh R, Tennant A, Biering-Sørensen F, Grimby G, Marincek C, Phillips S, Ring H, Tesio L, Thonnard JL. The use of outcome measures in physical medicine and rehabilitation within Europe. J Rehabil Med 2001, 33(6):273-8. 10.1080/165019701753236464, 11766957.
28. Moret-Hartman M, Reuzel R, Grin J, van der Wilt GJ. Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis. Health Care Anal 2008, 16(2):161-175. 10.1007/s10728-007-0069-1, 2362137, 17929170.
29. Flachenecker P, Khil L, Bergmann S, Kowalewski M, Pascu I, Pérez-Miralles F, Sastre-Garriga J, Zwingers T. Development and pilot phase of a European MS register. J Neurol 2010,
30. Prodinger B, Weise AP, Shaw L, Stamm TA. A Delphi study on environmental factors that impact work and social life participation of individuals with multiple sclerosis in Austria and Switzerland. Disabil Rehabil 2010, 32(3):183-95. 10.3109/09638280903071883, 20001824.
31. Kwakkel G. Towards integrative neurorehabilitation science. Physiother Res Int 2009, 14(3):137-146. 10.1002/pri.446, 19634129.
32. Hutchinson B, Forwell SJ, Bennett S, Brown T, Karpatkin H, Miller D. Toward a Consensus on Rehabilitation Outcomes in MS: Gait and Fatigue. Report of a CMSC Consensus Conference, November 28-29, 2007. Int J MS Care 2009, 11:67-78.
33. Gijbels D, Alders G, Van Hoof E, Charlier C, Roelants M, Broekmans T, Thijs H, Eijnde BO, Feys P. Predicting habitual walking performance in MS: relevance of capacity and self-report measures. Multiple Sclerosis 2010, 16(5):618-26. 10.1177/1352458510361357, 20207785.
34. Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP, et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001, 70(2):174-179. 10.1136/jnnp.70.2.174, 1737210, 11160464.
35. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, et al. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 1999, 52(1):57-62.
36. Rasova K, Brandejsky P, Havrdova E, Zalisova M, Foubikova B. Comparison of the influence of different rehabilitation programs on clinical spirometric and spiroergometric parameters in patients with multiple sclerosis. Multiple Sclerosis 2006, 12:227-234. 10.1191/135248506ms1248oa, 16629428.
37. Di Fabio RP, Soderberg J, Choi T, Hansen CR, Schapiro RT. Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 1998, 79(2):141-146. 10.1016/S0003-9993(98)90290-8, 9473994.
38. Lord SE, Wade DT, Halligan PW. A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study. Clin Rehabil 1998, 12(6):477-486. 10.1191/026921598675863454, 9869251.
39. Freeman D, Harris M. The philosophy of science and theories of case management. Case management for mentally ill patients 1993, 1-5. Harwood Accademic Publishers, Harris M, Bergman H.
40. Elola J, Daponte A, Navarro V. Health indicators and the organization of health care systems in western Europe. Am J Public Health 1995, 85(10):1397-401. 10.2105/AJPH.85.10.1397, 1615621, 7573624.
41. van Doorslaer E, Wagstaff A, van der Burg H, Christiansen T, De Graeve D, Duchesne I, Gerdtham UG, Gerfin M, Geurts J, Gross L, Häkkinen U, John J, Klavus J, Leu RE, Nolan B, O'Donnell O, Propper C, Puffer F, Schellhorn M, Sundberg G, Winkelhake O. Equity in the delivery of health care in Europe and the US. J Health Econ 2000, 19(5):553-83. 10.1016/S0167-6296(00)00050-3, 11184794.
42. Perkins MB, Jensen PS, Jaccard J, Gollwitzer P, Oettingen G, Pappadopulos E, Hoagwood KE. Applying theory-driven approaches to understanding and modifying clinicians' behavior: what do we know?. Psychiatr Serv 2007, 58(3):342-8. 10.1176/appi.ps.58.3.342, 17325107.
43. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999, 282(15):1458-65. 10.1001/jama.282.15.1458, 10535437.
44. Mauksch LB, Dugdale DC, Dodson S, Epstein R. Relationship, communication, and efficiency in the medical encounter: creating a clinical model from a literature review. Arch Intern Med 2008, 168(13):1387-95. 10.1001/archinte.168.13.1387, 18625918.
45. Faissner A, Kettenmann H, Trotter J. A critical review of contemporary therapies. Comprehensive Human Physiology 1996, 96-108. Springer-Verlag, Berlin, Greger R, Windhorst U.
46. Umphred DA, El-din D. Introduction. Theoretical Foundations for Clinical Practice Neurological Rehabilitation 2001, 3-31. Mosby, Inc., St. Luis Missouri, Umphred DA, Fourth.
47. Kolar P. Facilitation of Agonist-Antagonist Co-activation by Reflex Stimulation methods. Rehabilitation of the Spine 2007, Lippincott Williams & Wilkins, Craig Liebenson.
48. Wolf SL, Winstein CJ, Miller JP, Taub E, Uswatte G, Morris D, Giuliani C, Light KE, Nichols-Larsen D. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006, 296:2095-2104. 10.1001/jama.296.17.2095, 17077374.
49. Wolf SL, Blanton S, Baer H, Breshears J, Butler AJ. Repetitive task practice: a critical review of constraint-induced movement therapy in stroke. Neurologist 2002, 8(6):325-338. 10.1097/00127893-200211000-00001, 12801434.
50. Levin MF, Kleim JA, Wolf SL. What do motor "recovery" and "compensation" mean in patients following stroke?. Neurorehabil Neural Repair 2009, 23(4):313-319.
51. Shumway-Cook A, Woollacott MH. Motor control. Translating research into clinical praktice 2006, Lippincott Wiliams and Wilkins, Third.